Fidelity National [FNF] vs Ryan Specialty [RYAN] Detailed Stock Comparison
Fidelity National
NYSE
Loading...
Ryan Specialty
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Fidelity National wins in 14 metrics, Ryan Specialty wins in 5 metrics, with 0 ties. Fidelity National appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Fidelity National | Ryan Specialty | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.13 | 147.55 | Fidelity National |
| Price-to-Book Ratio | 2.05 | 12.30 | Fidelity National |
| Debt-to-Equity Ratio | 54.14 | 309.01 | Fidelity National |
| PEG Ratio | -1.55 | 18.69 | Fidelity National |
| EV/EBITDA | 7.03 | 15.05 | Fidelity National |
| Profit Margin (TTM) | 7.90% | 2.02% | Fidelity National |
| Operating Margin (TTM) | 12.01% | 23.84% | Ryan Specialty |
| EBITDA Margin (TTM) | 12.01% | 23.84% | Ryan Specialty |
| Return on Equity | 13.75% | 16.98% | Ryan Specialty |
| Return on Assets (TTM) | 1.15% | 3.48% | Ryan Specialty |
| Free Cash Flow (TTM) | $6.67B | $467.87M | Fidelity National |
| Dividend Yield | 2.73% | 0.51% | Fidelity National |
| 1-Year Return | 1.28% | -7.73% | Fidelity National |
| Price-to-Sales Ratio (TTM) | 1.19 | 5.66 | Fidelity National |
| Enterprise Value | $17.51B | $11.60B | Fidelity National |
| EV/Revenue Ratio | 1.29 | 4.21 | Fidelity National |
| Revenue per Share (TTM) | $50 | $22 | Fidelity National |
| Earnings per Share (Diluted) | $3.93 | $0.40 | Fidelity National |
| Beta (Stock Volatility) | 1.06 | 0.64 | Ryan Specialty |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Fidelity National vs Ryan Specialty Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Fidelity National | -0.34% | -0.83% | 8.52% | 2.52% | 1.81% | 6.23% |
| Ryan Specialty | 0.93% | -0.59% | -9.30% | -15.83% | -14.66% | -5.48% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Fidelity National | 1.28% | 53.59% | 84.92% | 132.30% | 608.82% | 300.74% |
| Ryan Specialty | -7.73% | 36.41% | 107.07% | 107.07% | 107.07% | 107.07% |
Performance & Financial Health Analysis: Fidelity National vs Ryan Specialty
| Metric | FNF | RYAN |
|---|---|---|
| Market Information | ||
| Market Cap | $16.16B | $15.58B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,430,720 | 1,335,130 |
| 90 Day Avg. Volume | 2,101,313 | 1,361,953 |
| Last Close | $59.27 | $59.75 |
| 52 Week Range | $50.61 - $66.72 | $55.77 - $77.16 |
| % from 52W High | -11.17% | -22.56% |
| All-Time High | $66.72 (Mar 31, 2025) | $77.16 (Mar 31, 2025) |
| % from All-Time High | -11.17% | -22.56% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.24% |
| Quarterly Earnings Growth | -0.09% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.02% |
| Operating Margin (TTM) | 0.12% | 0.24% |
| Return on Equity (TTM) | 0.14% | 0.17% |
| Debt to Equity (MRQ) | 54.14 | 309.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $29.07 | $4.80 |
| Cash per Share (MRQ) | $15.95 | $1.40 |
| Operating Cash Flow (TTM) | $6.87B | $571.34M |
| Levered Free Cash Flow (TTM) | $1.59B | $429.36M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.73% | 0.51% |
| Last 12-Month Dividend | $1.48 | $0.34 |
Valuation & Enterprise Metrics Analysis: Fidelity National vs Ryan Specialty
| Metric | FNF | RYAN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.13 | 147.55 |
| Forward P/E | 9.61 | 26.71 |
| PEG Ratio | -1.55 | 18.69 |
| Price to Sales (TTM) | 1.19 | 5.66 |
| Price to Book (MRQ) | 2.05 | 12.30 |
| Market Capitalization | ||
| Market Capitalization | $16.16B | $15.58B |
| Enterprise Value | $17.51B | $11.60B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.29 | 4.21 |
| Enterprise to EBITDA | 7.03 | 15.05 |
| Risk & Other Metrics | ||
| Beta | 1.06 | 0.64 |
| Book Value per Share (MRQ) | $29.07 | $4.80 |
Financial Statements Comparison: Fidelity National vs Ryan Specialty
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FNF | RYAN |
|---|---|---|
| Revenue/Sales | $3.58B | $690.17M |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $382.00M | $51.04M |
| Income Tax | $98.00M | $55.43M |
| Net Income (Profit) | $293.00M | $-4.39M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FNF | RYAN |
|---|---|---|
| Cash & Equivalents | $4.33B | $203.55M |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $4.77B | $3.81B |
| Total Shareholders Equity | $8.80B | $1.06B |
| Retained Earnings | $5.93B | $79.34M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FNF | RYAN |
|---|---|---|
| Operating Cash Flow | $150.00M | $-197.82M |
| Capital Expenditures | $-37.00M | N/A |
| Free Cash Flow | $1.08B | $-159.56M |
| Debt Repayment | $-300.00M | $-154.25M |
| Common Stock Repurchase | $-24.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FNF | RYAN |
|---|---|---|
| Shares Short | 3.96M | 4.93M |
| Short Ratio | 3.37 | 4.28 |
| Short % of Float | 0.02% | 0.04% |
| Average Daily Volume (10 Day) | 1,430,720 | 1,335,130 |
| Average Daily Volume (90 Day) | 2,101,313 | 1,361,953 |
| Shares Outstanding | 275.00M | 125.41M |
| Float Shares | 256.84M | 108.25M |
| % Held by Insiders | 0.06% | 0.14% |
| % Held by Institutions | 0.82% | 0.90% |
Dividend Analysis & Yield Comparison: Fidelity National vs Ryan Specialty
| Metric | FNF | RYAN |
|---|---|---|
| Last 12-Month Dividend | $1.48 | $0.34 |
| Last 12-Month Dividend Yield | 2.73% | 0.51% |
| 3-Year Avg Annual Dividend | $1.71 | $0.19 |
| 3-Year Avg Dividend Yield | 1.04% | 0.18% |
| 3-Year Total Dividends | $5.14 | $0.56 |
| Ex-Dividend Date | Mar 17, 2025 | Mar 04, 2025 |